Home >> Research Area >>Others>>Others>> Metiamide

Metiamide

Histamine H2-receptor antagonist CAS# 34839-70-8

Metiamide

Catalog No. BCC1742----Order now to get a substantial discount!

Product Name & Size Price Stock
Metiamide: 5mg $242 In Stock
Metiamide: 10mg Please Inquire In Stock
Metiamide: 20mg Please Inquire Please Inquire
Metiamide: 50mg Please Inquire Please Inquire
Metiamide: 100mg Please Inquire Please Inquire
Metiamide: 200mg Please Inquire Please Inquire
Metiamide: 500mg Please Inquire Please Inquire
Metiamide: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of Metiamide

Number of papers citing our products

Chemical structure

Metiamide

3D structure

Chemical Properties of Metiamide

Cas No. 34839-70-8 SDF Download SDF
PubChem ID 1548992 Appearance Powder
Formula C9H16N4S2 M.Wt 244.38
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : ≥ 2.4 mg/mL (9.82 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name 1-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]thiourea
SMILES CC1=C(N=CN1)CSCCNC(=S)NC
Standard InChIKey FPBPLBWLMYGIQR-UHFFFAOYSA-N
Standard InChI InChI=1S/C9H16N4S2/c1-7-8(13-6-12-7)5-15-4-3-11-9(14)10-2/h6H,3-5H2,1-2H3,(H,12,13)(H2,10,11,14)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of Metiamide

DescriptionMetiamide is an antagonist histamine H2-receptor
TargetsH2 receptor    

Metiamide Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Metiamide Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Metiamide

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 4.092 mL 20.4599 mL 40.9199 mL 81.8398 mL 102.2997 mL
5 mM 0.8184 mL 4.092 mL 8.184 mL 16.368 mL 20.4599 mL
10 mM 0.4092 mL 2.046 mL 4.092 mL 8.184 mL 10.23 mL
50 mM 0.0818 mL 0.4092 mL 0.8184 mL 1.6368 mL 2.046 mL
100 mM 0.0409 mL 0.2046 mL 0.4092 mL 0.8184 mL 1.023 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Metiamide

Metiamide is a high-selective and oral bioavailable antagonist of histamine H2-receptor with ED50 value of 25 μmol/kg [1].
Unlike the traditional antihistaminics which are H1-receptor antagonists, metiamide is an antagonist of H2-receptor. It is developed from burimamide which is a previously found antagonist of H2-receptor. Metiamide acts as a competitive antagonist and blocks the combination of histamine and its receptor. This blockade results in the inhibition of gastric acid secretion stimulated by histamine and other hormone such as pentagastrin and gastrin. Compared with burimamide, metiamide showed higher activity and good oral bioavailability [1 and 2].
In the in vitro assays, metiamide displayed about 10-fold higher activity than burimamide on rat uterine muscle and guinea-pig heart muscle with Kb values of 0.75 and 0.92 μM, respectively. The Kb value of burimamide on the atrial muscle was 7.8 μM. Besides that, metiamide showed no efficacy on H1-receptor and isoprenaline even at the concentration of 1 mM suggested that metiamide was also a selective antagonist. Moreover, metiamide was found to cause increase in chemokinesis and random migration in PMN cells similar to histamine. It was different that metiamide had no effects on the true chemotaxis whereas histamine significantly suppressed the chemotaxis, which demonstrated histamine affected neutrophil motility through the H2-receptor site [1 and 3].
In dogs, the administration of metiamide inhibited acid secretion stimulated by histamine from both the Heidenhain pouch and the gastric fistula. It also inhibited acid secretion stimulated by pentagastrin and liver extract from both the Heidenhain pouch and the main stomach. When metiamide was given by intravenous injection, the doses of it to cause 50% inhibition of the maximal histamine- and pentagastrin-stimulated acid secretion were 3.1 and 6.1 μmol/kg. When metiamide was given by oral administration, the ED50 value of it to cause inhibition was 16 μmol/kg [1 and 2].
References:
[1] Black J W, Duncan W A M, Emmett J C, et al. Metiamide—an orally active histamine H2-receptor antagonist. Agents and Actions, 1973, 3(3): 133-137.
[2] Grossman M I, Konturek S J. Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors. Gastroenterology, 1974, 66(4): 517-521.
[3] Anderson R, Glover A, Rabson A R. The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels. The Journal of Immunology, 1977, 118(5): 1690-1696.

Featured Products
New Products
 

References on Metiamide

Toxic effects of the histamine H(2) receptor antagonist metiamide on bone-marrow haemopoietic and stromal progenitor cells in vitro.[Pubmed:20702338]

Toxicol In Vitro. 1988;2(3):221-4.

The histamine H(2)-receptor antagonist, Metiamide has been shown to cause agranulocytosis in vivo. In vitro colony forming assays for bone-marrow stromal fibroblast progenitors (CFU-F) and granulocyte/macrophage progenitor cells (CFU-GM) were performed, using murine bone marrow, to assess the relative sensitivity of committed haemopoietic cells, and the marrow stromal microenvironment to Metiamide toxicity. CFU-F were more susceptible than CFU-GM to inhibition by Metiamide, with 50% inhibition of colony formation (ID(50)) at 17 and 180 mug/ml in the CFU-F and CFU-GM assays, respectively. Inhibition of CFU-GM required the continuous presence of the drug, while CFU-F were inhibited similarly by either short-term (20-hr) or prolonged (10-day) incubation with Metiamide (ID(50) 27 and 17 mug/ml, respectively). It is suggested that bone-marrow stromal cell damage may be an important contributory factor in the haemopoietic toxicity of Metiamide.

Orthogonal arrays of particles in the gastric parietal cell of the rat: differences between superficial and basal cells in the gland and after pentagastrin or metiamide treatment.[Pubmed:3085548]

Anat Rec. 1986 May;215(1):28-34.

The basolateral plasma membrane of gastric parietal cells is characterized by the presence of orthogonal arrays of particles revealed by the freeze-fracture technique. These arrays were quantitatively assessed in freeze-fracture replicas of the gastric mucosa at two different levels of the gastric gland and after pentagastrin and Metiamide treatment. The arrays were small and scarce in parietal cells located in the upper part of the gland, while they were markedly more abundant in parietal cells situated at the base of the gland. In both superficial and basal cells, the concentration of the arrays was significantly decreased after pentagastrin or Metiamide treatment. This decrease was not due to an increase in the surface area of the basal plasma membrane. These results indicate that the concentration of the orthogonal arrays is a distinctive feature between superficial and basal parietal cells and that the arrays can be modulated by parietal cell function.

Antagonism of hypotensive and bradycardic effects of centrally administered guanfacine by metiamide in anesthetized rabbits.[Pubmed:2865383]

Jpn Heart J. 1985 Jul;26(4):577-84.

In anesthetized rabbits, intracerebroventricular (ICV) administration of the alpha-adrenoceptor agonist, guanfacine, like clonidine, elicited dose-related falls in arterial blood pressure and heart rate. ICV pretreatment with the histamine H2-receptor antagonist, Metiamide, significantly reduced the hypotensive and bradycardic responses caused by ICV injection of either guanfacine or clonidine. The present results seem to indicate that the antagonistic effect of Metiamide against either guanfacine or clonidine is probably due to its alpha-adrenoceptor blocking action rather than its histamine H2-receptor blocking action, suggesting that these interactions might be of central origin.

Description

Metiamide (SK&F 92058) is a histamine H2-receptor antagonist developed from another H2 antagonist, burimamide.

Keywords:

Metiamide,34839-70-8,Natural Products,Others, buy Metiamide , Metiamide supplier , purchase Metiamide , Metiamide cost , Metiamide manufacturer , order Metiamide , high purity Metiamide

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: